Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials : The Lancet
Links shared publicly online about this topic.
- 2,277total visits
Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials : The Lancet
Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. By - Shantha MW Rajaratnam PhD, Mihael H Polymeropoulos MD, Denn...
View full resource at thelancet.com
Tags: Sleep Disorder, Insomnia, Doctor
Most Recently Shared on February 6, 2009 at 11:54 am By:
Melatonin agonist tasimelteon for transient insomnia after sleep-time shift: two randomised controlled trials - http://bit.ly/Ruw6
Advertisement
